HomeInsightsStock Comparison

Alembic Pharmaceuticals Ltd vs Roopa Industries Ltd Stock Comparison

Alembic Pharmaceuticals Ltd vs Roopa Industries Ltd Stock Comparison

Last Updated on: Jun 13, 2025

Key Highlights

  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 990.75 as of 12 Jun 15:30.
  • The P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.4 on March 2024 . This represents a CAGR of 21.01% over 5 yearsThe P/E Ratio of Roopa Industries Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10059 crore on March 2020 to ₹ 19309 crore on March 2024 . This represents a CAGR of 13.93% over 5 yearsThe Market Cap of Roopa Industries Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 1783 crore as compare to the Dec '24 revenue of ₹ 1702 crore. This represent the growth of 4.77% The revenue of Roopa Industries Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 285.46 crore as compare to the Dec '24 ebitda of ₹ 270.08 crore. This represent the growth of 5.69% The ebitda of Roopa Industries Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 120.6 crore to ₹ 156.63 crore over 8 quarters. This represents a CAGR of 13.96% The net profit of Roopa Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Alembic Pharmaceuticals Ltd changed from 19.45 % on March 2020 to 32.44 % on March 2024 . This represents a CAGR of 10.77% over 5 yearsThe Dividend Payout of Roopa Industries Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
  • As per the scheme of arrangement, the 'Pharmaceutical Undertaking' of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

About Roopa Industries Ltd

  • Roopa Industries Limited is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries.
  • The Company was incorporated in 1985 and operates into manufacturing and marketing of bulk drugs and intermediaries.
  • The Company became a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998.
  • Over the years, it has been a principal supplier to many companies in various countries. The Company handled critical and risky processes and have dependable technical expertise for carrying out any labyrinthine hazardous manufacturing operations.
  • It offers triphenyl phosphine for use as wittig reagent in the manufacture of pharmaceuticals and cosmetics; as catalyst in hydroformylation, isomerisation, and polymerisation of olefins; as catalysing and curing agent in a range of polymerization reactions, epoxy resins, and photopolymers; and as reducing and deoxygenating agent in quinones, epoxides, amine oxides, and sulfoxides.

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharmaceuticals AGM scheduled

Alembic Pharmaceuticals announced that the 15th Annual General Meeting(AGM) of the company...

Read more

11 Jun 2025 17:31

News

Alembic Pharma slips as USFDA issues four observations for Panelav API facility

According to a regulatory filing, the USFDA conducted an unannounced and routine current g...

Read more

02 Jun 2025 11:58

News

Alembic Pharma receives USFDA final approval for Bosutinib tablets

Bosutinib tablets are indicated for the treatment of adult patients with chronic, accelera...

Read more

30 May 2025 15:42

News

Alembic Pharma receives USFDA nod for Amlodipine and Atorvastatin Tablets

Amlodipine and Atorvastatin tablets are a combination medication used to treat high blood ...

Read more

23 May 2025 15:08

News

Alembic Pharmaceuticals receives USFDA approval for Rivaroxaban Tablets

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from...

Read more

15 May 2025 14:14

News

Alembic Pharma rises on USFDA approval for Rivaroxaban Tablets

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

15 May 2025 16:36

Roopa Industries Ltd News Hub

News

Roopa Industries schedules board meeting

Roopa Industries will hold a meeting of the Board of Directors of the Company on 30 May 20...

Read more

21 May 2025 13:02

News

Roopa Industries to discuss results

Roopa Industries will hold a meeting of the Board of Directors of the Company on 14 Februa...

Read more

08 Feb 2025 17:25

News

Roopa Industries to convene board meeting

Roopa Industries will hold a meeting of the Board of Directors of the Company on 14 Novemb...

Read more

06 Nov 2024 20:37

News

Roopa Industries to hold AGM

Roopa Industries announced that the Annual General Meeting (AGM) of the company will be he...

Read more

11 Sep 2024 10:42

News

Roopa Industries to conduct AGM

Roopa Industries announced that the Annual General Meeting (AGM) of the company will be he...

Read more

11 Sep 2024 09:54

News

Roopa Industries to announce Quarterly Result

Roopa Industries will hold a meeting of the Board of Directors of the Company on 14 August...

Read more

06 Aug 2024 14:27

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Roopa Industries Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Roopa Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alembic Pharmaceuticals Ltd and Roopa Industries Ltd

Which company has a larger market capitalization, Alembic Pharmaceuticals Ltd or Roopa Industries Ltd?

Market cap of Alembic Pharmaceuticals Ltd is 19,474 Cr while Market cap of Roopa Industries Ltd is 48 Cr

What are the key factors driving the stock performance of Alembic Pharmaceuticals Ltd and Roopa Industries Ltd?

The stock performance of Alembic Pharmaceuticals Ltd and Roopa Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alembic Pharmaceuticals Ltd and Roopa Industries Ltd?

As of June 13, 2025, the Alembic Pharmaceuticals Ltd stock price is INR ₹990.75. On the other hand, Roopa Industries Ltd stock price is INR ₹61.04.

How do dividend payouts of Alembic Pharmaceuticals Ltd and Roopa Industries Ltd compare?

To compare the dividend payouts of Alembic Pharmaceuticals Ltd and Roopa Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions